Ikervis for DED Due to GVHD Post Allo-HSCT

Clinical trial NCT04636918 · UNKNOWN

Trial details

NCT number: NCT04636918
Sponsor: Singapore Eye Research Institute
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Leukemia (Both ALL and AML)MDS-EB-1

Start date: 2019-11-28
Primary completion: 2022-08-22
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.